| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kelly Jared | Chief Executive Officer, Director | C/O ONCOLYTICS BIOTECH INC., 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO | /s/ Kirk Look, Attorney-in-Fact | 13 Mar 2026 | 0002103581 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ONCY | Common Shares | Purchase | $4,848 | +5,050 | +4.6% | $0.9600 | 114,050 | 12 Mar 2026 | Direct |